Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cipla
Pharma
BMS, China reimbursement update, CAR-T hold—Fierce Pharma Asia
BMS signed a massive ADC deal. AZ and Gilead's ADCs passed on China's national insurance scheme. The FDA put three CARsgen CAR-Ts on clinical hold.
Angus Liu
Dec 15, 2023 5:15am
Cipla unit recalls anti-seizure drug because of faulty packaging
Dec 12, 2023 8:43am
AstraZeneca, BeiGene, Coherus—Fierce Pharma Asia
Dec 1, 2023 8:34am
Cipla plant slammed with FDA warning letter for ongoing problems
Nov 27, 2023 10:30am
BeiGene, PeptiDream and Biocon—Fierce Pharma Asia
Sep 22, 2023 8:50am
Torrent eyes a play for rival Cipla: Reuters
Sep 19, 2023 11:20am